| Treatment paradigm for an anti-cd19 antibody and venetoclax combination … |
2022-10-20 |
2022-12-01 |
|
| Combinations and uses thereof |
2022-10-03 |
2022-12-01 |
|
| Treatment for rheumatoid arthritis |
2022-8-25 |
2022-11-09 |
|
| Combinations of antigen binding molecules |
2022-7-27 |
2023-2-02 |
|
| Treatment of anti-pla2r autoantibody-mediated membranous nephropathy |
2022-7-19 |
2023-1-26 |
|
| Anti-betacellulin antibodies, fragments thereof, and multi-specific binding … |
2022-6-30 |
2022-11-03 |
|
| Combination of anti-cd19 antibody and bcl-2 inhibitor and use of the same |
2022-6-22 |
2022-9-21 |
|
| Antibody drug conjugates for ablating hematopoietic stem cells |
2022-6-06 |
2022-9-29 |
|
| Methods for predicting therapeutic benefit of anti-cd19 therapy in patients |
2022-5-25 |
2022-9-08 |
|
| Anti-CD19 antibody formulation |
2022-5-18 |
2022-8-17 |
|
| Method to increase antibody yield during ion exchange chromatography |
2022-5-16 |
2022-7-01 |
|
| Eluate collection during antibody chromatography |
2022-5-11 |
2022-7-01 |
|
| Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor … |
2022-4-28 |
2022-5-19 |
|
| Sequential anti-cd19 therapy |
2022-4-24 |
2022-6-01 |
|
| Anti-tumor combination therapy comprising anti-cd19 antibody and gamma delta t- … |
2022-4-13 |
2022-6-01 |
|
| Anti-cd19 therapy in combination with lenalidomide for the treatment of … |
2022-4-12 |
2022-6-01 |
|
| Anti-cd38 antibodies for use in the treatment of antibody-mediated transplant … |
2022-3-01 |
2022-9-09 |
|
| Clinical assessment of m-protein response in multiple myeloma |
2022-2-03 |
2022-4-12 |
|
| Anti-cd38 antibodies and their uses |
2022-1-14 |
2022-9-16 |
|
| FAB Molecules with a Rodent Hinge Region and a Non-Rodent CH1 Region |
2022-1-10 |
2022-5-05 |
|
| Anti-cd19 combination therapy |
2021-12-03 |
2022-6-16 |
|
| Anti-cd19 therapy in patients having a limited number of nk cells |
2021-10-12 |
2021-12-01 |
|
| Novel human antibodies binding to human CD3 epsilon |
2021-9-22 |
2023-3-09 |
|
| Combination therapies targeting c5ar and pd-1/pd-l1 pathways |
2021-9-17 |
2022-3-24 |
|
| Anti-cd38 antibodies and pharmaceutical compositions thereof for the treatment … |
2021-9-13 |
2021-10-31 |
|
| Antibodies targeting c5ar |
2021-9-09 |
2021-10-31 |
|
| Il-18 binding molecules |
2021-7-27 |
2022-3-31 |
|
| Compositions and methods for antibodies targeting epo |
2021-7-22 |
2021-11-18 |
|
| Antibodies for il-17c |
2021-7-02 |
2021-10-01 |
|
| Anti-tumor combination therapy comprising an anti-CD 19 antibody and a … |
2021-6-22 |
2023-4-11 |
|
| Anti-tumor combination therapy comprising anti-cd19 antibody and polypeptides … |
2021-6-22 |
2021-12-30 |
|
| Natriuretic peptide receptor 1 antibodies and methods of use |
2021-6-16 |
2022-11-10 |
|
| Antibody formulations |
2021-6-10 |
2021-7-29 |
|
| GENERATION AND PROFILING OF FULLY HUMAN HuCAL GOLD-DERIVED THERAPEUTIC … |
2021-6-09 |
2021-9-23 |
|
| Anti-gm-csf antibodies |
2021-5-07 |
2021-11-11 |
|
| Treatment for multiple myeloma (mm) |
2021-5-06 |
2021-9-09 |
|
| Canine antibody libraries |
2021-4-22 |
2021-10-14 |
|
| Pharmaceutical combinations for treating tumor comprising anti-cd19 antibody … |
2021-3-12 |
2022-2-28 |
|
| Pharmaceutical combinations for treating tumor comprising anti-cd19 antibody … |
2021-2-15 |
2021-4-07 |
|
| High concentration liquid antibody formulations |
2020-12-31 |
2021-3-01 |
|
| Anti-wt1/hla-specific antibodies |
2020-10-13 |
2021-1-28 |
|
| Entpd2 antibodies, combination therapies, and methods of using the antibodies … |
2020-9-17 |
2022-11-03 |
|
| Combination therapy with entpd2 and cd73 antibodies |
2020-9-17 |
2022-10-27 |
|
| Peptide libraries |
2020-9-08 |
2020-12-24 |
|
| Novel methods for displaying cyclic peptides on bacteriophage particles |
2020-8-12 |
2020-12-10 |
|
| Antibodies for epidermal growth factor receptor 3 (her3) |
2020-7-27 |
2021-1-14 |
|
| Complex-specific antibodies and antibody fragments and its use |
2020-7-10 |
2020-10-29 |
|
| Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the … |
2020-7-01 |
2020-10-15 |
|
| Ckit antibody drug conjugates |
2020-6-04 |
2020-12-31 |
|
| Polypeptide library |
2020-4-08 |
2020-7-23 |
|
| Combinations and uses thereof |
2020-4-03 |
2020-11-12 |
|
| Combinations and uses thereof |
2020-4-03 |
2020-11-12 |
|
| Treatment for rheumatoid arthritis |
2020-1-10 |
2020-5-21 |
|
| Antibody drug conjugates |
2019-12-09 |
2020-4-30 |
|
| Multispecific antigen-binding molecules |
2019-12-04 |
2022-2-10 |
|
| TREM2 stabilizing antibodies |
2019-10-14 |
2022-11-08 |
2022-11-08 |
| Antibodies for il-17c |
2019-8-05 |
2020-1-09 |
|
| Antibody drug conjugates for ablating hematopoietic stem cells |
2019-6-19 |
2021-7-29 |
|
| Entpd2 antibodies, combination therapies, and methods of using the antibodies … |
2019-5-29 |
2021-5-27 |
|
| Antibodies targeting glycoprotein vi |
2019-5-15 |
2021-3-24 |
|
| Antibody formulation |
2019-3-06 |
2019-6-27 |
|
| Antibodies and pharmaceutical compositions thereof for the treatment of … |
2019-3-05 |
2019-9-12 |
|
| Antagonists of il-17c for the treatment and/or prevention of atopic dermatitis |
2018-12-21 |
2019-10-18 |
|
| Antibody drug conjugates |
2018-12-19 |
2019-11-14 |
|
| Antagonists of IL17C for the treatment of inflammatory disorders |
2018-11-08 |
2020-10-27 |
2020-10-27 |
| A collection of antibody sequences its use |
2018-10-31 |
2018-12-28 |
|
| Treatment of atopic dermatitis |
2018-9-25 |
2020-8-05 |
|
| Antibodies for epidermal growth factor receptor 3 (her3) |
2018-9-11 |
2019-6-27 |
|
| Humanized antibodies for cd3 |
2018-8-13 |
2020-6-24 |
|
| Antibodies targeting bone morphogenetic protein 9 (bmp9) and methods therefor |
2018-7-05 |
2019-5-23 |
|
| Treatment paradigm for an anti-cd19 antibody and venetoclax combination … |
2018-5-30 |
2021-9-23 |
|
| Compositions and methods for antibodies targeting factor p |
2018-5-07 |
2018-11-15 |
|
| Method for the treatment of pain and osteoarthritis with c-fms antagonists |
2018-4-17 |
2018-8-23 |
|
| Compositions and methods for increasing muscle growth |
2018-2-27 |
2018-7-12 |
|
| Anti-cd38 human antibodies and uses therefor |
2018-1-11 |
2018-8-02 |
|
| Factor XI antibodies and methods of use |
2017-12-21 |
2021-11-09 |
2021-11-09 |
| Combinations and uses thereof |
2017-12-19 |
2018-2-23 |
|
| Antibodies targeting m-csf |
2017-10-27 |
2018-3-01 |
|
| Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti- … |
2017-8-07 |
2019-6-04 |
2019-6-04 |
| Simultaneous detection of biomolecules in biological entities |
2017-7-26 |
2017-11-09 |
|
| Anti-cd19 antibody formulations |
2017-6-27 |
|
|
| Anti-CD19 antibody formulations |
2017-6-27 |
2022-7-01 |
|
| Methods of predicting therapeutic benefit of CD19 antibody therapy in a patient |
2017-5-30 |
2023-4-07 |
|
| Methods for predicting therapeutic benefit of anti-CD19 therapy in patients |
2017-5-30 |
2022-7-01 |
|
| Rodent combinatorial antibody libraries |
2017-3-10 |
2021-2-16 |
2021-2-16 |
| Collection and methods for its use |
2017-3-03 |
2020-5-12 |
2020-5-12 |
| Antibodies for il-17c |
2017-2-17 |
2021-6-25 |
|
| TGFbeta 2 Antibodies |
2017-2-17 |
2019-3-28 |
|
| ANTIBODIES FOR IL-17C |
2017-2-16 |
2018-5-16 |
|
| Anti-bsep-specific antibodies |
2017-1-23 |
2017-7-27 |
|
| Lectin-like oxidized ldl receptor 1 antibodies and methods of use |
2016-12-23 |
2017-9-14 |
|
| Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the … |
2016-9-07 |
2018-6-19 |
2018-6-19 |
| Anti-cd38 human antibody and use thereof |
2016-6-03 |
2016-9-08 |
|
| Therapeutic combinations of anti -cd20 and anti - gm - csf antibodies and uses … |
2016-3-18 |
2016-4-07 |
|
| Antibodies against notch 3 |
2015-9-14 |
2018-1-11 |
|
| Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use |
2015-8-06 |
2018-6-05 |
2018-6-05 |
| Antibodies for guanylyl cyclase receptors |
2015-6-19 |
2016-6-16 |
|
| Fusion proteins and uses thereof |
2015-6-09 |
2017-5-04 |
|
| 包括抗-CD19抗体和阻断SIRPα-CD47先天免疫检查点的多肽的抗肿瘤组合疗法 |
2021-6-22 |
2023-4-11 |
|
| 预测cd19抗体治疗在患者中的治疗益处的方法 |
2017-5-30 |
2023-4-07 |
|